UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000034768
Receipt number R000039630
Scientific Title Effects of cardiac therapeutic interventions on cerebral blood flow
Date of disclosure of the study information 2018/11/07
Last modified on 2021/11/08 08:49:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of cardiac therapeutic interventions on cerebral blood flow

Acronym

Cerebral blood flow changes from cardiac therapeutic interventions

Scientific Title

Effects of cardiac therapeutic interventions on cerebral blood flow

Scientific Title:Acronym

Cerebral blood flow changes from cardiac therapeutic interventions

Region

Japan


Condition

Condition

chronic thromboembolic pulmonary hypertension and atrial fibrillation

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To test if balloon pulmonary angioplasty and catheter ablation improve cerebral perfusion in patients with chronic thromboembolic pulmonary hypertension and those with atrial fibrillation, respectively.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Cerebral blood flow

Key secondary outcomes

Psychological test scores
Correlations between cerebral blood flow and psychological test scores


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

45 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients are diagnosed as chronic thromboembolic pulmonary hypertension in fully meeting with the following criteria 1-3.

1.Chronic thrombi detected by perfusion scintigraphy, pulmonary angiography, and/or contrast computed tomography.
2.Mean pulmonary artery pressure more or equal with 25mmhg
3.Pulmonary artery wedge pressure less or equal with 15mmHg

Paroxysmal and persistent atrial fibrillation are defined as atrial fibrillation which returns to sinus rhythm within 7 days and that persisting more than 7 days, respectively.

Key exclusion criteria

1.Patients with organic brain diseases such as dementia and massive cerebral stroke
2.Patients with unstable hemodynamic and/or respiratory conditions
3.Patients with psychiatric diseases

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Hideaki
Middle name
Last name Suzuki

Organization

Tohoku Medical Megabank Ogranization

Division name

Department of community medical supports

Zip code

980-8573

Address

2-1, Seiryo, Aoba, Sendai, Japan

TEL

022-717-7153

Email

hd.suzuki.1870031@cardio.med.tohoku.ac.jp


Public contact

Name of contact person

1st name Hideaki
Middle name
Last name Suzuki

Organization

Tohoku Medical Megabank Ogranization

Division name

Department of community medical supports

Zip code

980-8573

Address

2-1, Seiryo, Aoba, Sendai, Japan

TEL

022-717-7153

Homepage URL


Email

hd.suzuki.1870031@cardio.med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics application office in Tohoku University Hospital

Address

Sendai, Aoba, Seiryo, 1-1

Tel

022-717-7122

Email

ec@rinri.hosp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 11 Month 07 Day


Related information

URL releasing protocol

https://upload.umin.ac.jp/cgi-bin/ctr/ctr_view_reg.cgi?recptno=R000039630

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

24

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 11 Month 05 Day

Date of IRB

2018 Year 11 Month 08 Day

Anticipated trial start date

2018 Year 11 Month 12 Day

Last follow-up date

2024 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Cerebral blood flow measurement with 99mTC ECD SPECT


Management information

Registered date

2018 Year 11 Month 05 Day

Last modified on

2021 Year 11 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000039630


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name